VCID: 288497
Profile
Corporate information
Official name
Compound Therapeutics Incorporated
Registration country
Official name
Compound Therapeutics Incorporated
Registration country
Investment activity status
Active investor
Company type
Biotechnology company focused on protein-based drugs.Funding
Funding rounds
(1 Mar 2003) Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Atlas Venture LLP | Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. | United Kingdom | Initial investment. Round participant. |
|
Flagship Ventures | Venture capital firm | United States | Initial investment. Round participant. |
|
Polaris Venture Partners Inc | Multistage venture capital investors with focus Technology, Healthcare and Consumer | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Atlas Venture LLP Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. |
Series A | |
|
|
Flagship Ventures Venture capital firm |
+1 (617) 868-1888 |
Series A |
|
|
Polaris Venture Partners Inc Multistage venture capital investors with focus Technology, Healthcare and Consumer |
+1 (781) 290-0770 |
Series A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Phylos Inc Biotechnology company specializing in the genomics and proteomics fields. |
United States | 9 Mar 2004 | N/A USD 4,000,000 (USD 4,000,000) deal size. |